Tessier-Lavigne Marc (CIK 1437435) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-06-05). Recent activity: Buy DNLI (6,037 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-06-05 | Denali Therapeutics Inc. (DNLI) | Director | Buy | 6,037 | $0 |
Source: SEC Form 4 filings · as of 2025-06-05